Page 82 - IJAMD-1-1

International Journal of AI
for Material and Design MMDB: A comprehensive biofabrication database

organ-on-a-chip, and organoid, which hold the potential To address these challenges, there is a pressing need for
5
6
to revolutionize healthcare by addressing organ shortages a comprehensive database that can serve as a repository
and enabling the development of personalized treatments. of knowledge in the field of organ manufacturing.
Within this domain, 3D bioprinting emerges as a pivotal Such a database would not only provide a reference for
technique, representing a subset of biofabrication experimental design for researchers in the field but also
specifically focused on the layer-by-layer construction of serve as a valuable resource for those outside the field
3D structures from bioinks. Bioinks consist of materials seeking to understand the intricacies of biofabrication. 16,17
containing living cells and biomaterials, underlining While several databases have been developed in related
3D bioprinting’s pivotal role in advancing the broader fields, such as the organ-on-a-chip database (OOCDB),
18
field of biofabrication. In addition, it is pertinent to the bioink database for extrusion-based 3D printing,
19
delve into the various 3D bioprinting techniques, as and the stem cell line database, these databases provide
20
classified by American Society for Testing and Materials valuable resources for researchers, offering insights into
standards: extrusion-based, jetting-based, and vat the design and fabrication of organ-on-a-chip systems
photopolymerization-based bioprinting. Each technique and biomaterials, respectively. However, there is a distinct
comes with distinct material requirements. For instance, lack of a comprehensive database specifically dedicated to
extrusion-based bioprinting necessitates bioinks with organ manufacturing.
specific rheological properties to maintain shape fidelity The proposed organ manufacturing database aims to
post-deposition. Meanwhile, jetting-based bioprinting fill this gap. By systematically analyzing and quantifying
demands materials with particular viscosity and surface previous research outcomes, the database will provide a
tension characteristics for accurate droplet formation and robust platform for the development of machine learning
placement. Vat photopolymerization, on the other hand, models that can optimize organ manufacturing parameters
7
requires photosensitive resins that can be precisely cured and functional indicators. This advancement will not
21
with light to form intricate structures. Understanding only accelerate research in the field but also facilitate
8
these material requirements is fundamental for advancing the translation of biofabrication technologies from the
organ manufacturing. laboratory to the clinic. Compared to existing databases
Despite these advancements, the challenges persist like OOCDB, the proposed organ manufacturing database
in the field of organ manufacturing. One of the primary offers several unique features. First, the manufacturing
challenges is the complexity of biological systems, mainly multi-organs database (MMDB) zeroes in on the realm of
stemming from the limited functionalities of bioprinted organ manufacturing, offering a comprehensive overview
tissues compared to their native counterparts. For instance, of inherent properties, chemical reactions (crosslinking,
while recent advancements have enabled the bioprinting of modification), biocompatibility characteristics, and
tissues with basic structural and cellular components, these market translation information for materials used in organ
bioprinted tissues often lack the full range of biological fabrication. Second, the integration of machine learning
functions inherent in natural tissues, such as intricate techniques enhances the optimization of manufacturing
vascular networks and dynamic cellular interactions. processing parameters and organ functional indicators.
9
Replicating this complexity in a laboratory setting proves This aspect is crucial, given the intricacies of biological
to be a daunting task. 10,11 In addition, the customization systems and the imperative for precision in organ
22,23
potential of bioprinting introduces significant regulatory manufacturing.
challenges. Navigating the regulatory landscape for In summary, the establishment of an organ
personalized bioprinted products is complex, as current manufacturing database is of paramount importance.
frameworks are primarily designed for mass-produced This database will serve as a crucial resource for both
medical devices and pharmaceuticals. Addressing these researchers and non-specialists, fostering collaboration
challenges necessitates a reevaluation of regulatory policies and innovation in the field of biofabrication. In addition,
to accommodate the unique aspects of bioprinted tissues it will provide a platform for the application of machine
and organs, ensuring safety and efficacy while fostering learning techniques, paving the way for the next generation
innovation. The use of different techniques and materials of biofabrication technologies.
12
across laboratories presents another challenge, making
it difficult to compare results across studies. 13,14 This lack 2. Methods
of standardization further hinders the translation of Figure 1 depicts the construction process of MMDB,
biofabrication technologies from the laboratory to the involving a sequence of detailed steps. This process
clinic. 15 commences with the collection and structuring of data

Volume 1 Issue 1 (2024) 76 https://doi.org/10.36922/ijamd.2420